Arthur R. Brothman

10.9k total citations · 1 hit paper
122 papers, 5.1k citations indexed

About

Arthur R. Brothman is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arthur R. Brothman has authored 122 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 51 papers in Molecular Biology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arthur R. Brothman's work include Genomic variations and chromosomal abnormalities (46 papers), Prostate Cancer Treatment and Research (24 papers) and Prenatal Screening and Diagnostics (23 papers). Arthur R. Brothman is often cited by papers focused on Genomic variations and chromosomal abnormalities (46 papers), Prostate Cancer Treatment and Research (24 papers) and Prenatal Screening and Diagnostics (23 papers). Arthur R. Brothman collaborates with scholars based in United States, United Kingdom and Germany. Arthur R. Brothman's co-authors include Charles Lee, A. John Iafrate, John C. Carey, Teresa M. Maxwell, Xiao Lin Zhu, Briana J. Williams, L. Ralph Rohr, Xue‐Xue Zhu, Lisa G. Shaffer and Sarah T. South and has published in prestigious journals such as Nature Medicine, Nature Genetics and PLoS ONE.

In The Last Decade

Arthur R. Brothman

120 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

2011 548 citations Arthur R. Brothman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arthur R. Brothman United States	39	2.4k	1.9k	1.5k	990	682	122	5.1k
Charles H.C.M. Buys Netherlands	42	3.2k 1.3×	1.5k 0.8×	822 0.5×	1.3k 1.3×	606 0.9×	155	7.0k
Jeffrey M. Conroy United States	31	1.7k 0.7×	1.5k 0.8×	479 0.3×	787 0.8×	291 0.4×	133	3.7k
Maurizio Genuardi Italy	38	2.3k 1.0×	1.7k 0.9×	357 0.2×	1.1k 1.2×	341 0.5×	203	5.1k
Ruth Gershoni‐Baruch Israel	39	3.1k 1.3×	1.7k 0.9×	400 0.3×	573 0.6×	351 0.5×	145	6.1k
Dicky Halley Netherlands	36	1.8k 0.7×	1.6k 0.8×	714 0.5×	211 0.2×	373 0.5×	129	5.2k
Christophe Béroud France	41	4.2k 1.7×	1.7k 0.9×	749 0.5×	1.4k 1.4×	210 0.3×	117	7.2k
Javier Benı́tez Spain	51	3.9k 1.6×	2.1k 1.1×	619 0.4×	2.1k 2.1×	174 0.3×	243	7.6k
Edward V. Ball United Kingdom	17	3.8k 1.6×	2.4k 1.2×	279 0.2×	558 0.6×	162 0.2×	23	5.9k
Vijay G. Sankaran United States	45	4.7k 1.9×	961 0.5×	386 0.3×	906 0.9×	1.1k 1.6×	146	7.7k
Alfons Meindl Germany	37	3.4k 1.4×	2.0k 1.1×	521 0.3×	965 1.0×	116 0.2×	76	5.7k

Countries citing papers authored by Arthur R. Brothman

Since Specialization

Citations

This map shows the geographic impact of Arthur R. Brothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur R. Brothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur R. Brothman more than expected).

Fields of papers citing papers by Arthur R. Brothman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur R. Brothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur R. Brothman. The network helps show where Arthur R. Brothman may publish in the future.

Co-authorship network of co-authors of Arthur R. Brothman

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur R. Brothman. A scholar is included among the top collaborators of Arthur R. Brothman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur R. Brothman. Arthur R. Brothman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brothman, Arthur R., Michelle Dolan, Barbara K. Goodman, et al.. (2011). College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genetics in Medicine. 13(9). 765–769. 12 indexed citations

Gu, Guangyu & Arthur R. Brothman. (2011). Cytogenomic aberrations associated with prostate cancer. Cancer Genetics. 204(2). 57–67. 3 indexed citations

Brothman, Arthur R., Diane L. Persons, & Lisa G. Shaffer. (2009). Nomenclature Evolution: Changes in the ISCN from the 2005 to the 2009 Edition. Cytogenetic and Genome Research. 127(1). 1–4. 73 indexed citations

Curry, Cynthia J., Rong Mao, Emily Aston, et al.. (2008). Homozygous deletions of a copy number change detected by array CGH: A new cause for mental retardation?. American Journal of Medical Genetics Part A. 146A(15). 1903–1910. 10 indexed citations

Bleyl, Steven B., Janice L. B. Byrne, Sarah T. South, et al.. (2007). Brachymesomelic dysplasia with Peters anomaly of the eye results from disruptions of the X chromosome near the SHOX and SOX3 genes. American Journal of Medical Genetics Part A. 143A(23). 2785–2795. 13 indexed citations

Brothman, Arthur R., et al.. (2005). Section E6 of the ACMG technical standards and guidelines: Chromosome studies for acquired abnormalitie: This updated Section E6 has been incorporated into Section E: Clinical Cytogenetics of the 2005 ACMG Standards and Guidelines for Clinical Genetics Laboratories and supersedes the previous section E6. Genetics in Medicine. 7(7). 509–513. 2 indexed citations

Pettus, Joseph A., Teresa M. Maxwell, Brett Milash, et al.. (2004). Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics. Cancer Genetics and Cytogenetics. 154(2). 110–118. 12 indexed citations

Hong, Bo, Zhong Chen, Cheryl M. Coffin, et al.. (2003). Molecular cytogenetic analysis of a pleuropulmonary blastoma. Cancer Genetics and Cytogenetics. 142(1). 65–69. 10 indexed citations

Nagle, Raymond B., Patrick C. Roche, Eric D. Hsi, et al.. (2002). Clinical laboratory assays for HER-2/neu amplification and overexpression: Quality assurance, standardization, and proficiency testing. Archives of Pathology & Laboratory Medicine. 126(7). 803–808. 65 indexed citations

10.

Mascarello, James T., Arthur R. Brothman, Gordon W. Dewald, et al.. (2002). Proficiency Testing for Laboratories Performing Fluorescence In Situ Hybridization With Chromosome-Specific DNA Probes. Archives of Pathology & Laboratory Medicine. 126(12). 1458–1462. 16 indexed citations

11.

Pyne, Michael T., et al.. (2000). The BRCA2 genetic variant IVS7 + 2T → G is a mutation. Journal of Human Genetics. 45(6). 351–357. 19 indexed citations

12.

Chen, Zhong, et al.. (2000). Nonrandom Rearrangements of 6p in Malignant Hematological Disorders. Cancer Genetics and Cytogenetics. 121(1). 22–25. 15 indexed citations

13.

Brothman, Arthur R., et al.. (1999). Chromosomal clues to the development of prostate tumors. The Prostate. 38(4). 303–312. 5 indexed citations

14.

Jiang, Cui, et al.. (1998). Chromosome 7 Abnormalities in Prostate Cancer Detected by Dual-Color Fluorescence In Situ Hybridization. Cancer Genetics and Cytogenetics. 107(1). 51–60. 28 indexed citations

15.

Jackson‐Cook, Colleen, et al.. (1996). Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genetics and Cytogenetics. 87(1). 14–23. 47 indexed citations

16.

Yin, Xiaoying, et al.. (1995). Mutation of the MXI1 gene in prostate cancer. Nature Genetics. 9(3). 249–255. 160 indexed citations

17.

Brothman, Arthur R., et al.. (1992). Confirmation of true mosaic trisomy 20 in a phenotypically normal liveborn male. Clinical Genetics. 42(1). 47–49. 8 indexed citations

18.

Brothman, Arthur R., et al.. (1991). Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genetics and Cytogenetics. 55(1). 79–84. 46 indexed citations

19.

Kraemer, Paul M., et al.. (1986). Spontaneous Immortalization Rate of Cultured Chinese Hamster Cells2. JNCI Journal of the National Cancer Institute. 76(4). 703–709. 54 indexed citations

20.

Liskamp, Rob M. J., et al.. (1985). Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promoters. Biochemical and Biophysical Research Communications. 131(2). 920–927. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact